Author:
Helderman N.C.,Lucas M.W.,Blank C.U.
Subject
Oncology,Immunology and Allergy
Reference98 articles.
1. Immune checkpoint inhibitors: recent progress and potential biomarkers;Darvin;Exp Mol Med,2018
2. A decade of immune-checkpoint inhibitors in cancer therapy;Robert;Nat Commun,2020
3. Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067;Hodi;J Clin Oncol,2022
4. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance;Martins;Nat Rev Clin Oncol,2019
5. Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial;Ascierto;Lancet Oncol,2020
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献